Dear Colleagues,


It is our great pleasure to announce that the Turkish Association for Psychopharmacology (TAP)'s 13th International Congress on Psychopharmacology & International Symposium on Child and Adolescent Psychopharmacology (ICP 2022) will be held on November 09-12, 2022 in Antalya, Turkey.


After a hybrid edition, we are happy to invite you to join us again in an entire face-to-face meeting and make the ICP 2022 a memorable event. The motto of the congress is Overcoming Challenges: Psychiatry and Psychopharmacology in the Post-pandemic era. During this four-day congress; distinguished national and international speakers and researchers will provide up-to-date information and the latest outstanding breakthroughs in psychopharmacology as well as other fields of clinical practice along with interactively sharing the latest trends in treatment-resistant cases and will offer practical solutions to contemporary challenges clinicians face and also review the latest developments in basic sciences, biological psychiatry, neuroscience, and psychiatric neuroimaging. Additionally, we aim to contribute to the integrative approach in psychiatric treatments through comprehensive discussions about diagnostic approaches, psychotherapies and other non-pharmacological treatments, and their administration standards and guidelines, which are bolstered by the most up-to-date clinical research.



Panel-Course-Workshop etc. Proposal Submission Deadline
07 September 2022

Early Registration Deadline
09 September 2022

Abstract Submission Deadline
15 September 2022

Award, Scholarship Application Deadline
15 September 2022

Brief Report Application Deadline
15 September 2022

Revision Sending Deadline
09 October 2022
E-Poster "JPEG & PDF" Sending Deadline
09 October 2022

Registration of Accepted Abstracts Deadline
10 October 2022

Full Paper Submission Date
22 October 2022

Speech Text Submission Date
22 October 2022

Congress Dates
09 - 12 November 2022


Follow the ICP  to stay up to date on the latest ICP 2022 activities, congress news, related articles, opportunities for collaborative research, scientific information and more.